UCSF and TPMG’s Division of Research received major funds for a study comparing the effectiveness of blood-thinning medications that prevent clots in the veins and lungs.
There was a 40 percent reduction in all types of heart attacks across Kaiser Permanente in Northern California from the peak in 2000 through 2014, the most recently studied year.
A new study of more than 2,200 patients with low risk prostate cancer in an ethnically and economically diverse population revealed that ethnicity influences the decision to switch from observation only to active treatment.
Kaiser Permanente Northern California Division of Research will partner with the University of California, Davis, Alzheimer's Disease Center to undertake state-of-the-art brain imaging and cognitive testing of study participants, with funding from the National Institute on Aging.
A surgical procedure recommended to reduce the future risk of ovarian cancer has been successfully implemented throughout Kaiser Permanente in Northern California without a change in surgical outcomes.
After more than a decade of steady improvements, the decline in mortality rates from heart disease and stroke has slowed nationally and nearly leveled out since 2011, according to a new analysis from Kaiser Permanente published in JAMA Cardiology.
An international team of researchers has discovered a new way to predict which women with gestational diabetes will develop type 2 diabetes after delivery.
Second-born children who are conceived sooner than two years or later than six years after the arrival of their older sibling have a substantially increased risk of autism spectrum disorders (ASDs), according to a new Kaiser Permanente study published in the journal Pediatrics.
The timely administration of a clot-dissolving treatment for emergency department stroke patients nearly doubled following the introduction of new technology, according to a study published on September 8, 2015 in the Annals of Emergency Medicine.
In one of the first and largest evaluations of the use of preexposure prophylaxis (PrEP) to prevent HIV infection in a clinical practice setting, researchers at Kaiser Permanente found no new HIV infections among patients during more than 2.5 years of observation. The study was published on Sept. 2, 2015 in the journal Clinical Infectious Diseases.
